Feline Coronavirus Clinical Trial Completed
About the Research:
Our clinical study is a study on Feline Corona Viruses from the family Coronaviridae, including SARS-CoV-2, which caused the Covid19 pandemic.
Corona Virus takes the form of infection called FIP (Feline Infectious Peritonitis) by passing one or more mutations in the body in cats. FIP is an infection that does not have a valid treatment yet and causes simultaneous multi-organ failure and results in death of more than 90% of the patients.
Research Content:
|
Pathogen |
Feline Corona Virus |
|
Disease Name |
FCoV – Efusive (Wet) FIP, Neurological (Dry) FIP |
|
Patient Group |
Owned Cats |
|
Age group |
6-60 Monthly |
|
Gender |
Male and female |
|
Research Center |
3 Centers |
|
Number of patients |
20 Cats |
|
Results: |
|
|
Progression Level |
%100 |
|
Treatment Effectiveness Rate |
%95 |
Treatment Applied in the Study:
Signal Therapy is applied only with the Dr Biolyse® device in patients. No supportive drugs or chemicals are used.
Scope of Treatment Effectiveness:
1- In the effusive (Wet) FIP form:
- Improvement of inflammation in internal organs,
- Improvement of vascular damage,
- The effusion accumulating in the abdomen gradually disappears over time,
- Hematological and biochemical values returned to normal,
- It has been observed that the general conditions have improved.
2- In the Neurological (Dry) FIP Form:
- Inflammation in the spinal cord and central nervous system is healed,
- Loss of vision and hearing returns to normal,
- The uveitis picture in the eye is resolved,
- The tongue and pharynx are working again,
- It was observed that the hematological and biochemical values returned to normal.
No serious adverse effects were found.
May 2022